In depression, GSK3β abnormal activation suppresses BDNF expression, which regulates neural proliferation, neurogenesis, synaptic plasticity, and apoptosis (Bath et al., 2012; Bramham and Panja, 2014). This evidence concerns the gene BDNF and depressive symptom measurement.